TITLE

Making AIDS treatment affordable for all sufferers

AUTHOR(S)
Sanders, Bernie
PUB. DATE
December 2011
SOURCE
Hill;12/1/2011, Vol. 18 Issue 165, p14
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
In this article, the author discusses the affordable treatment for AIDS/HIV.
ACCESSION #
69856575

 

Related Articles

  • More Drug Reports. Helquist, Michael // Advocate;3/18/86, Issue 442, p25 

    Reports that researchers at the AIDS branch of the U.S. Centers for Disease Control continue to conduct tests of potentially therapeutic agents to be used against AIDS. Ability of rifabutin to block the in vitro infectivity and replication of the AIDS virus; Ability of rifabutin to penetrate...

  • HALTING HIV.  // Science Teacher;Sep2000, Vol. 67 Issue 6, p14 

    Reports that researchers have created a molecule, an HIV integrase inhibitor, that appears to survive in cells longer than existing treatments to combat the virus that leads to AIDS. Mechanism of action of the potential drug; Steps in the reproduction of HIV.

  • Aids Drug Available In United Kingdom. Helquist, Michael // Advocate;1/19/88, Issue 490, p9 

    Reports on the availability in Great Britain AL-721, a drug for treating AIDS. Physicians' basis for prescribing the drug; Status in the United States; Start of the U.S. National Institutes of Health's study of its effectiveness against persistent generalized lymphadenopathy.

  • CNE/CME QUESTIONS.  // AIDS Alert;May2010, Vol. 25 Issue 5, p59 

    A quiz is presented related to medical care for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) patients.

  • DIA GNOSIS DÉ JÀ VU. Correia, Tony // Xtra West (Vancouver);1/28/2010, Issue 429, p12 

    The author shares his struggle of fighting HIV/AIDS virus infection on his own by not taking medications advised by physicians.

  • Another AIDS teaser. Gorman, Christine; Sancton, Thomas A. // Time;11/8/1993, Vol. 142 Issue 19, p71 

    Recounts the announcement by biologist Ara Hovanessian (France's Pasteur Institute) that his research team had found a second receptor, CD26, that helps the HIV virus enter the cells of the immune system. Possible drug treatments to block access to the CD26 receptor, thus preventing infection;...

  • Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic. Wambui, Veronica; Kiptoo, Michael; Kinyua, Joyceline; Odera, Irene; Muge, Edward; Muiruri, Peter; Lihana, Raphael; Kinyanjui, Peter; Songok, Elijah M. // AIDS Research & Therapy;2012, Vol. 9, p22 

    Background: CCR5 antagonists have clinically been approved for prevention or treatment of HIV/AIDS. Countries in Sub-Saharan Africa with the highest burden of HIV/AIDS are due to adopt these regimens. However, HIV-1 can also use CXCR4 as a co-receptor. There is hence an urgent need to map out...

  • CNE/CME questions.  // AIDS Alert;Feb2009, Vol. 24 Issue 2, p23 

    A quiz concerning the treatment for HIV and AIDS is presented.

  • JUST SAY NO. Martindale, Diane // New Scientist;9/15/2001, Vol. 171 Issue 2308, p28 

    Discusses an AIDS therapy called 'structured treatment interruptions,' an on-again, off-again treatment regimen that allows the immune system to build to the point where it can hold the virus in check. Improvement in the quality of life of the patient; More affordable cost of the therapy;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics